AstraZeneca to test combining Oxford vaccine with Sputnik V vaccine
AstraZeneca, which is developing a coronavirus vaccine with Oxford University, said it would investigate combining its vaccine with Russia's Sputnik V vaccine. "Being able to combine different vaccines may be helpful to improve protection and/or to improve vaccine accessibility," AstraZeneca said. A 'mix and match' trial between AstraZeneca and Pfizer's COVID-19 vaccines was announced earlier.